Challenges associated with the integration of immuno-oncology agents in clinical practice.

ABSTRACT:

Background

The availability of new immuno-oncology therapeutics markedly impacts oncology clinicians' treatment decision-making. To effectively support healthcare professionals (HCPs) in their practice, it is important to better understand the challenges and barriers that can accompany the introduction of these agents. This study aimed to establish the types and causes of clinical challenges posed by the introduction of new immuno-oncology agents.

Methods

The mixed-methods design included qualitative in-depth interviews and group discussions with HCPs, in which participants discussed clinical challenges and potential underlying reasons for these challenges. Qualitative findings informed a quantitative survey. This survey investigated the extent and distribution of challenges

SUBMITTER: Lazure P 

PROVIDER: S-EPMC9652913 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature